Sirolimus‐ and cyclosporine‐loaded nanostructured lipid carriers: Development, characterization, and in vitro evaluation in T‐cell profiles of patients with a history of recurrent pregnancy loss

PURPOSE: The authors developed nanostructured lipid carriers (NLCs) loaded with sirolimus (SRL) and cyclosporine (CsA) to improve their therapeutic efficacy in recurrent pregnancy loss (RPL) patients. METHODS: Mono‐delivery and co‐delivery of SRL and CsA by NLCs (S‐NLCs, C‐NLCs, and S‐C‐NLCs) were d...

Descripción completa

Detalles Bibliográficos
Autores principales: Parhizkar, Forough, Yousefi, Mehdi, Soltani‐Zangbar, Mohammad Sadegh, Parhizkar, Zahra, Aghebati‐Maleki, Leili, Abbaspour‐Ravasjani, Soheil, Motavalli, Roza, Alizadegan, Amin, Mojahedi, Maryam, Baharaghdam, Sina, Kamrani, Amin, Danaii, Shahla, Talebi, Mehdi, Jadidi‐Niaragh, Farhad, Hamishehkar, Hamed, Kafil, Hossein Samadi, Mahmoodpoor, Ata, Heris, Javad Ahmadian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026110/
https://www.ncbi.nlm.nih.gov/pubmed/36949822
http://dx.doi.org/10.1002/rmb2.12509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026110/
https://www.ncbi.nlm.nih.gov/pubmed/36949822
http://dx.doi.org/10.1002/rmb2.12509

Ejemplares similares